(FM) Unidad de Medicina Traslacional
Departamento académico
Hospital Clinic Barcelona
Barcelona, EspañaPublications en collaboration avec des chercheurs de Hospital Clinic Barcelona (12)
2022
-
FlowCT for the analysis of large immunophenotypic data sets and biomarker discovery in cancer immunology
Blood Advances, Vol. 6, Núm. 2, pp. 690-703
-
Laboratory Cross-Comparison and Ring Test Trial for Tumor BRCA Testing in a Multicenter Epithelial Ovarian Cancer Series: The BORNEO GEICO 60-0 Study
Journal of Personalized Medicine, Vol. 12, Núm. 11
-
NGS-Based Molecular Karyotyping of Multiple Myeloma: Results from the GEM12 Clinical Trial
Cancers, Vol. 14, Núm. 20
2021
-
Deep MRD profiling defines outcome and unveils different modes of treatment resistance in standard- And high-risk myeloma
Blood, Vol. 137, Núm. 1, pp. 49-60
2020
-
Biological and clinical significance of dysplastic hematopoiesis in patients with newly diagnosed multiple myeloma
Blood, Vol. 135, Núm. 26, pp. 2375-2387
-
Circulating tumor cells for comprehensive and multiregional non-invasive genetic characterization of multiple myeloma
Leukemia, Vol. 34, Núm. 11, pp. 3007-3018
2017
-
Differentiation stage of myeloma plasma cells: Biological and clinical significance
Leukemia, Vol. 31, Núm. 2, pp. 382-392
2016
-
Phenotypic and genomic analysis of multiple myeloma minimal residual disease tumor cells: A new model to understand chemoresistance
Blood, Vol. 127, Núm. 15, pp. 1896-1906
2005
-
Oxidation of specific methionine and tryptophan residues of apolipoprotein A-I in hepatocarcinogenesis
Proteomics, Vol. 5, Núm. 18, pp. 4964-4972
2004
-
Genetic diagnosis by comparative genomic hybridization in adult de novo acute myelocytic leukemia
Cancer Genetics and Cytogenetics, Vol. 153, Núm. 1, pp. 16-25
-
Methylthioadenosine phosphorylase gene expression is impaired in human liver cirrhosis and hepatocarcinoma
Biochimica et Biophysica Acta - Molecular Basis of Disease, Vol. 1690, Núm. 3, pp. 276-284
2003
-
Imatinib mesylate (STI571) treatment in patients with chronic-phase chronic myelogenous leukaemia previously submitted to autologous stem cell transplantation
British Journal of Haematology, Vol. 120, Núm. 3, pp. 500-504